Conmed's market cap is currently $1.50B. The company's EPS TTM is $1.15; its P/E ratio is 13.71; and it has a dividend yield of 1.65%. Conmed is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $1.05. See an overview of income statement, balance sheet, and cash flow financials.
